|
US20030138438A1
(en)
|
1998-03-18 |
2003-07-24 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US20030236209A1
(en)
|
1998-03-18 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US6436703B1
(en)
*
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
WO2002020036A1
(de)
|
2000-09-06 |
2002-03-14 |
Mueller Friederike |
Arzneimittel mit einer für das rna-bindende koc-protein kodierenden dna-sequenz, einem koc-protein oder einer dna-sequenz des koc-promotors
|
|
US7919467B2
(en)
|
2000-12-04 |
2011-04-05 |
Immunotope, Inc. |
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
|
DE602008000891D1
(de)
|
2008-04-30 |
2010-05-12 |
Immatics Biotechnologies Gmbh |
Neuartige Formulierungen von Tumor-assoziierten Peptiden, welche an menschliche Leukozytenantigene der Klasse I oder II für Impfungen binden
|
|
US20100037514A1
(en)
|
2008-05-13 |
2010-02-18 |
Afton Chemical Corporation |
Fuel additives to maintain optimum injector performance
|
|
RS53872B2
(sr)
*
|
2008-05-14 |
2018-06-29 |
Immatics Biotechnologies Gmbh |
Novi i snažni mhc peptidi klase ii izvedeni iz survivina i neurokana
|
|
RS53782B1
(sr)
|
2008-10-01 |
2015-06-30 |
Immatics Biotechnologies Gmbh |
Preparati tumor-asociranih peptida i odgovarajuća antikancerska vakcina za tretman glioblastoma (gbm) i drugih kancera
|
|
US8253536B2
(en)
|
2009-04-22 |
2012-08-28 |
Simon Fraser University |
Security document with electroactive polymer power source and nano-optical display
|
|
TW201124530A
(en)
|
2009-12-01 |
2011-07-16 |
Oncotherapy Science Inc |
IMP-3 oligopeptides and vaccines including the same
|
|
AU2011227283A1
(en)
|
2010-03-16 |
2012-11-08 |
Adapta Medical, Inc. |
Catheter reservoir seals
|
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201015765D0
(en)
|
2010-09-21 |
2010-10-27 |
Immatics Biotechnologies Gmbh |
Use of myeloid cell biomarkers for the diagnosis of cancer
|
|
SG189517A1
(en)
|
2010-10-25 |
2013-05-31 |
Stepan Co |
Laundry detergents based on compositions derived from natural oil metathesis
|
|
GB201021289D0
(en)
|
2010-12-15 |
2011-01-26 |
Immatics Biotechnologies Gmbh |
Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer
|
|
DK2663580T3
(en)
|
2011-01-10 |
2017-03-13 |
Ct Atlantic Ltd |
COMBINATION THERAPY INCLUDING TUMOR ASSOCIATED ANTI-BINDING ANTIBODIES
|
|
WO2014089124A1
(en)
|
2012-12-03 |
2014-06-12 |
Cenexys, Inc. |
Immunogenic compositions for inducing an immune response for elimination of senescent cells
|
|
JP6548579B2
(ja)
|
2012-12-06 |
2019-07-24 |
ヴィクトリア リンク リミテッド |
コンジュゲート化合物
|
|
ES2897579T3
(es)
|
2013-06-10 |
2022-03-01 |
Dana Farber Cancer Inst Inc |
Métodos y composiciones para reducir la inmunosupresión por células tumorales
|
|
GB201319446D0
(en)
*
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
WO2015123496A1
(en)
|
2014-02-14 |
2015-08-20 |
Immune Design Corp. |
Immunotherapy of cancer through combination of local and systemic immune stimulation
|
|
ES2900262T3
(es)
|
2014-03-17 |
2022-03-16 |
Bundesrepublik Deutschland Letztvertreten Durch Das Robert Koch Inst Vertreten Durch Seinen Praeside |
Un medicamento para el uso en un método para inducir o extender una respuesta inmunitaria citotóxica celular
|
|
JP2015227292A
(ja)
|
2014-05-30 |
2015-12-17 |
国立大学法人高知大学 |
膵がん細胞浸潤転移抑制ワクチン
|
|
US10046046B2
(en)
|
2014-06-05 |
2018-08-14 |
Victoria Link Limited |
Amino sphingoglycolipid analogues
|
|
GB201504502D0
(en)
|
2015-03-17 |
2015-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
|
|
FI3273986T3
(fi)
*
|
2015-03-27 |
2024-02-07 |
Immatics Biotechnologies Gmbh |
Uusia peptidejä ja peptidien yhdistelmiä käytettäväksi immunoterapiassa eri syöpiä vastaan
|
|
GB201505305D0
(en)
*
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
GB201505585D0
(en)
*
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
|
GB201507030D0
(en)
*
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
CN107810193B
(zh)
*
|
2015-05-06 |
2022-03-22 |
伊玛提克斯生物技术有限公司 |
用于结直肠癌(crc)和其他癌症免疫治疗的新型肽和肽组合物及其支架
|
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
CA2989483A1
(en)
*
|
2015-06-19 |
2016-12-22 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers
|
|
GB201510771D0
(en)
*
|
2015-06-19 |
2015-08-05 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
|
|
GB201511546D0
(en)
*
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
EP3919507A3
(en)
*
|
2015-07-01 |
2022-01-12 |
Immatics Biotechnologies GmbH |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
GB201521746D0
(en)
*
|
2015-12-10 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
|
|
GB201604490D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides combination of peptides for use in immunotherapy against cancers
|
|
PL3430037T3
(pl)
*
|
2016-03-16 |
2022-12-19 |
Immatics Biotechnologies Gmbh |
Transfekowane komórki t oraz receptory komórek t do stosowania w immunoterapii przeciwnowotworowej
|
|
GB201604494D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Transfected T-Cells and T-Cell receptors for use in immunotherapy against cancers
|
|
US10357550B2
(en)
|
2016-04-06 |
2019-07-23 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
|
|
GB201609193D0
(en)
|
2016-05-25 |
2016-07-06 |
Immatics Biotechnologies Gmbh |
Novel peptides, combination of peptides as targets for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
|
|
TWI796299B
(zh)
|
2016-08-26 |
2023-03-21 |
德商英麥提克生物技術股份有限公司 |
用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架
|
|
BR112019028280A2
(pt)
|
2017-07-04 |
2020-07-14 |
Curevac Ag |
moléculas de ácido nucleico
|
|
EP3679065A4
(en)
|
2017-09-06 |
2021-05-19 |
California Institute of Technology |
SIGNALING AND ANTIGEN-PRESENTING BIFUNCTIONAL RECEPTORS (SABR)
|
|
WO2020072700A1
(en)
|
2018-10-02 |
2020-04-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
|
JP2022096002A
(ja)
|
2019-04-25 |
2022-06-29 |
三洋化成工業株式会社 |
アルカリ電池用ゲル化剤及びアルカリ電池
|
|
AU2020356334A1
(en)
|
2019-09-24 |
2022-03-31 |
Université Catholique de Louvain |
Modified vesicular stomatitis virus glycoprotein and uses thereof for the treatment of brain tumors
|
|
US12394502B2
(en)
|
2019-10-02 |
2025-08-19 |
The General Hospital Corporation |
Method for predicting HLA-binding peptides using protein structural features
|